Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma

Takahiko Katoh, Robert Boissy, Naoki Nagata, Kyoko Kitagawa, Yusuke Kuroda, Hideaki Itoh, Toshihiro Kawamoto, Douglas A. Bell

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

The polymorphic arylamine N-acetyltransferases (NAT1 and NAT2) have been implicated in increased susceptibility to certain malignancies. We analyzed genetic polymorphisms in both the NAT1 and NAT2 genes among 140 gastric adenocarcinoma patients, 103 colorectal adenocarcinoma patients and 122 healthy controls from Japan. The frequency of the specific genotype NAT1*10 allele, which contains a variant polyadenylation signal, was higher among all gastric adenocarcinoma cases, but this increase did not reach statistical significance. After grouping according to tumor differentiation of gastric adenocarcinoma patients, NAT1 polymorphism was a risk factor among the well- differentiated type of tumors (OR = 3.03, 95% CI 1.08-8.46). Stratifying by smoking status, we found that the OR for heavy smokers with the NAT1*10 allele was 2.97 (95% CI 1.23-7.14). When the combined risk of NAT1*10 allele from smoking and tumor differentiation was calculated, we found that the risk of the NAT1*10 allele with heavy smoking was increased among the well- differentiated type of gastric adenocarcinoma (OR = 4.24, 95% CI 0.87-20.6). The NAT1*10 genotype was not a significant risk factor in colorectal adenocarcinoma. No statistically significant differences were observed in the frequency of NAT2 rapid acetylation genotype in gastric (91.4%) or colorectal (95.2%) adenocarcinoma patients when compared with the control population (94.3%). Our results suggest the NAT1*10 allele may be an important genetic determinant of the well-differentiated type of gastric adenocarcinoma, which may be induced by smoking.

Original languageEnglish (US)
Pages (from-to)46-49
Number of pages4
JournalInternational Journal of Cancer
Volume85
Issue number1
DOIs
StatePublished - Jan 1 2000

Fingerprint

Stomach
Adenocarcinoma
Genes
Alleles
Smoking
Genotype
Neoplasms
Arylamine N-Acetyltransferase
N-acetyltransferase 1
Polyadenylation
Genetic Polymorphisms
Acetylation
Japan
Population

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma. / Katoh, Takahiko; Boissy, Robert; Nagata, Naoki; Kitagawa, Kyoko; Kuroda, Yusuke; Itoh, Hideaki; Kawamoto, Toshihiro; Bell, Douglas A.

In: International Journal of Cancer, Vol. 85, No. 1, 01.01.2000, p. 46-49.

Research output: Contribution to journalArticle

Katoh, Takahiko ; Boissy, Robert ; Nagata, Naoki ; Kitagawa, Kyoko ; Kuroda, Yusuke ; Itoh, Hideaki ; Kawamoto, Toshihiro ; Bell, Douglas A. / Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma. In: International Journal of Cancer. 2000 ; Vol. 85, No. 1. pp. 46-49.
@article{0467e926b4524bb2be9b471035fb15d7,
title = "Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma",
abstract = "The polymorphic arylamine N-acetyltransferases (NAT1 and NAT2) have been implicated in increased susceptibility to certain malignancies. We analyzed genetic polymorphisms in both the NAT1 and NAT2 genes among 140 gastric adenocarcinoma patients, 103 colorectal adenocarcinoma patients and 122 healthy controls from Japan. The frequency of the specific genotype NAT1*10 allele, which contains a variant polyadenylation signal, was higher among all gastric adenocarcinoma cases, but this increase did not reach statistical significance. After grouping according to tumor differentiation of gastric adenocarcinoma patients, NAT1 polymorphism was a risk factor among the well- differentiated type of tumors (OR = 3.03, 95{\%} CI 1.08-8.46). Stratifying by smoking status, we found that the OR for heavy smokers with the NAT1*10 allele was 2.97 (95{\%} CI 1.23-7.14). When the combined risk of NAT1*10 allele from smoking and tumor differentiation was calculated, we found that the risk of the NAT1*10 allele with heavy smoking was increased among the well- differentiated type of gastric adenocarcinoma (OR = 4.24, 95{\%} CI 0.87-20.6). The NAT1*10 genotype was not a significant risk factor in colorectal adenocarcinoma. No statistically significant differences were observed in the frequency of NAT2 rapid acetylation genotype in gastric (91.4{\%}) or colorectal (95.2{\%}) adenocarcinoma patients when compared with the control population (94.3{\%}). Our results suggest the NAT1*10 allele may be an important genetic determinant of the well-differentiated type of gastric adenocarcinoma, which may be induced by smoking.",
author = "Takahiko Katoh and Robert Boissy and Naoki Nagata and Kyoko Kitagawa and Yusuke Kuroda and Hideaki Itoh and Toshihiro Kawamoto and Bell, {Douglas A.}",
year = "2000",
month = "1",
day = "1",
doi = "10.1002/(SICI)1097-0215(20000101)85:1<46::AID-IJC8>3.0.CO;2-0",
language = "English (US)",
volume = "85",
pages = "46--49",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma

AU - Katoh, Takahiko

AU - Boissy, Robert

AU - Nagata, Naoki

AU - Kitagawa, Kyoko

AU - Kuroda, Yusuke

AU - Itoh, Hideaki

AU - Kawamoto, Toshihiro

AU - Bell, Douglas A.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - The polymorphic arylamine N-acetyltransferases (NAT1 and NAT2) have been implicated in increased susceptibility to certain malignancies. We analyzed genetic polymorphisms in both the NAT1 and NAT2 genes among 140 gastric adenocarcinoma patients, 103 colorectal adenocarcinoma patients and 122 healthy controls from Japan. The frequency of the specific genotype NAT1*10 allele, which contains a variant polyadenylation signal, was higher among all gastric adenocarcinoma cases, but this increase did not reach statistical significance. After grouping according to tumor differentiation of gastric adenocarcinoma patients, NAT1 polymorphism was a risk factor among the well- differentiated type of tumors (OR = 3.03, 95% CI 1.08-8.46). Stratifying by smoking status, we found that the OR for heavy smokers with the NAT1*10 allele was 2.97 (95% CI 1.23-7.14). When the combined risk of NAT1*10 allele from smoking and tumor differentiation was calculated, we found that the risk of the NAT1*10 allele with heavy smoking was increased among the well- differentiated type of gastric adenocarcinoma (OR = 4.24, 95% CI 0.87-20.6). The NAT1*10 genotype was not a significant risk factor in colorectal adenocarcinoma. No statistically significant differences were observed in the frequency of NAT2 rapid acetylation genotype in gastric (91.4%) or colorectal (95.2%) adenocarcinoma patients when compared with the control population (94.3%). Our results suggest the NAT1*10 allele may be an important genetic determinant of the well-differentiated type of gastric adenocarcinoma, which may be induced by smoking.

AB - The polymorphic arylamine N-acetyltransferases (NAT1 and NAT2) have been implicated in increased susceptibility to certain malignancies. We analyzed genetic polymorphisms in both the NAT1 and NAT2 genes among 140 gastric adenocarcinoma patients, 103 colorectal adenocarcinoma patients and 122 healthy controls from Japan. The frequency of the specific genotype NAT1*10 allele, which contains a variant polyadenylation signal, was higher among all gastric adenocarcinoma cases, but this increase did not reach statistical significance. After grouping according to tumor differentiation of gastric adenocarcinoma patients, NAT1 polymorphism was a risk factor among the well- differentiated type of tumors (OR = 3.03, 95% CI 1.08-8.46). Stratifying by smoking status, we found that the OR for heavy smokers with the NAT1*10 allele was 2.97 (95% CI 1.23-7.14). When the combined risk of NAT1*10 allele from smoking and tumor differentiation was calculated, we found that the risk of the NAT1*10 allele with heavy smoking was increased among the well- differentiated type of gastric adenocarcinoma (OR = 4.24, 95% CI 0.87-20.6). The NAT1*10 genotype was not a significant risk factor in colorectal adenocarcinoma. No statistically significant differences were observed in the frequency of NAT2 rapid acetylation genotype in gastric (91.4%) or colorectal (95.2%) adenocarcinoma patients when compared with the control population (94.3%). Our results suggest the NAT1*10 allele may be an important genetic determinant of the well-differentiated type of gastric adenocarcinoma, which may be induced by smoking.

UR - http://www.scopus.com/inward/record.url?scp=0033991169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033991169&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(20000101)85:1<46::AID-IJC8>3.0.CO;2-0

DO - 10.1002/(SICI)1097-0215(20000101)85:1<46::AID-IJC8>3.0.CO;2-0

M3 - Article

C2 - 10585581

AN - SCOPUS:0033991169

VL - 85

SP - 46

EP - 49

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 1

ER -